Division of Cardiology, Department of Medicine, West Virginia University, Morgantown.
Department of Cardiology, Mayo Clinic School of Medicine, Rochester, Minnesota.
JAMA Intern Med. 2020 May 1;180(5):783-784. doi: 10.1001/jamainternmed.2019.6767.
This survey study evaluates the early post–US Food and Drug Administration approval experience with an embolic protection device used during transcatheter aortic valve replacement procedures.
这项调查研究评估了经美国食品和药物管理局批准后,在经导管主动脉瓣置换术期间使用栓塞保护装置的早期经验。